MedPath

Magnetic Resonance Imaging Using Innovative Pulse Sequences

Not Applicable
Completed
Conditions
Clinical Indication for a Head MRI
Interventions
Device: pulse sequences
Registration Number
NCT01724216
Lead Sponsor
GE Healthcare
Brief Summary

The purpose of the study is to collect in vivo human image data to demonstrate neurological magnetic resonance imaging (MRI) of subjects using short pulse sequences.

Detailed Description

This is a single-site; open-label, prospective research Study involving human subjects. There will be no comparative efficacy or safety analysis and therefore no randomization

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Subject must be at least 18 years of age
  • Subject must be willing and able to undergo verbal and written informed consent
  • Subject must have a clinical indication for a head MRI with and without Gadolinium-based contrast agent administration
Exclusion Criteria
  • Subjects who have any of the conditions below at the time of the enrollment or scan session are excluded from this study. Further, should it be determined by study staff that an enrolled subject meets any of the conditions below during the course of the study, the subject will be removed from the study.

    • Any contraindication to an MRI scan per the policy of Spectrum Health
    • Any contraindication to administration of an MRI contrast agent per the policy of Spectrum Health
    • Off-label utilization of contrast agents administered for the subject's clinical exam

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
pulse sequence softwarepulse sequencesThe central aim of this study is to acquire a set of images and associated technical and clinical information to facilitate regulatory submission of the pulse sequences being studied by GEHC. Segment 1 allows to collect a minimum of 10 subjects then evaluate if additional scans/enrollment needed Segment 2 will allow an additional 90 subjects if data needed
Primary Outcome Measures
NameTimeMethod
Number of Head Images Successfully Collected6-months

Collect head human images and associated technical and clinical information to demonstrate neurological magnetic resonance imaging of subjects using short pulse sequence.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Spectrum Health

🇺🇸

Grand Rapids, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath